{"id":"W4405040001","doi":"10.1182/blood-2024-205985","title":"Zilovertamab Vedotin in Combination with Nemtabrutinib for Patients with Relapsed or Refractory Mantle Cell Lymphoma: Cohort C of the Open-Label, Phase 2 Waveline-006 Study","year":2024,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC","funders":"","keywords":"Mantle cell lymphoma; Medicine; Internal medicine; Refractory (planetary science); Open label; Oncology; Phases of clinical research; Cohort; Lymphoma; Clinical trial; Materials science","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001598405,0.001039751,0.001202553,0.0003443235,0.000482555,0.001247513,0.0008208597,0.0007682021,0.003159169],"category_scores_gemma":[0.001123864,0.0004122055,0.001839149,0.0004358065,0.0004243746,0.0007994358,0.0005253011,0.001959467,0.0008479066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001475542,"about_ca_system_score_gemma":0.002284434,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002650383,"about_ca_topic_score_gemma":0.006157907,"domain_scores_codex":[0.9995353,0.0001574556,0.00003360851,0.0001105403,0.0000666257,0.00009644868],"domain_scores_gemma":[0.9990957,0.00009533409,0.0002138224,0.00009828652,0.0001181167,0.0003787821],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6634204,0.03173465,0.1532119,0.001511554,0.006665252,0.0006971876,0.0005435894,0.002728122,0.02536065,0.0005257481,0.0229053,0.09069564],"study_design_scores_gemma":[0.4674818,0.2073997,0.2804411,0.0002927194,0.005837303,0.001607598,0.0004205161,0.003429651,0.004654505,0.0006782169,0.02760506,0.0001518275],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846647,0.001828247,0.0003860666,0.0003557228,0.00007810001,0.002873049,0.007567732,0.00005610642,0.002190276],"genre_scores_gemma":[0.9701417,0.001803363,0.001507046,0.00138753,0.0002386403,0.003192555,0.01971474,0.00004003781,0.001974429],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003159169,"threshold_uncertainty_score":0.01070589,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01704880867454163,"score_gpt":0.2905989565411042,"score_spread":0.2735501478665626,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}